Page 4 - Best Esophageal cancer doctors: TOP 122 doctors

Dr. Ozden specializes in esophageal cancer treatment with extensive training in medical oncology.

• Graduated from Istanbul University's Cerrahpaşa Faculty of Medicine
• Completed medical oncology subspecialty at Kocaeli University
• Over a decade of experience in internal medicine and oncology
• Practices at VM Medical Park Pendik Hospital

Head of the Gastroenterology Department at Asklepios Altona Clinic, specializing in esophageal cancer treatments.

• Extensive experience in managing complex gastrointestinal conditions
• Leads a dedicated team focused on esophageal cancer care
• Works at a renowned clinic with advanced treatment facilities

Dr. Muzaffer Al specializes in advanced laparoscopic and oncological cancer surgery, with extensive training at top medical institutions.

• Trained in laparoscopic surgery at Istanbul University Çapa Faculty of Medicine
• Specialized in laparoscopic antireflux surgery and advanced laparoscopic bariatric surgery
• Experience in oncological cancer surgery, including esophageal cancer

Assoc. Prof. Nail Paksoy specializes in esophageal cancer treatment at Medipol Bahçelievler Hospital, with extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Participated in 8 international clinical trials for various cancers
• Published multiple studies on cancer treatment outcomes
• Fellowship-trained at Istanbul University Oncology Institute

Professor Gul Alco specializes in radiation oncology with over 20 years of experience, currently at Istanbul Medipol University.

• Trained at Istanbul University and Kadir Has University
• Associate Professor and later Professor at Demiroglu Bilim University
• Expert in radiation oncology for cancer treatment
• Works at Medipol Acibadem District Hospital

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Ezgi Sevic specializes in nutrition for cancer patients, with a focus on esophageal cancer. She graduated as an honor student from Hacettepe University.

• Completed studies on insulin resistance and obesity
• Worked in oncology hospitals and community health centers
• Expert in post-bariatric surgery nutrition
• Advanced English proficiency for international patients

30+ years in immunology with a focus on virotherapy – Dr. Jaunalksne brings cutting-edge immunotherapy expertise to esophageal cancer treatment.

• Specializes in virotherapy, a novel approach to cancer treatment
• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Graduate of Riga Medical Institute

Specializes in oncological surgery with expertise in esophageal cancer at Büyük Anadolu Hospitals.

• Experienced in pancreatic and bile duct surgeries
• Skilled in gastric and colon cancer procedures
• Performs bariatric metabolic and diabetes surgeries

Radiotherapist specializing in esophageal cancer treatment at Assuta Medical Center.

• Focuses on precise radiation therapy techniques
• Works with multidisciplinary teams for comprehensive care
• Utilizes advanced imaging for targeted treatment

Professor Jablonski-Perec trained at the renowned Sloan-Kettering Cancer Center – bringing world-class esophageal cancer expertise to Hadassah Medical Center.

• Head of Institute of Oncology at Hadassah
• Professor at Hebrew University's Department of Oncology
• Member of international cancer research communities
• Recipient of Hadassah Medical School scholarship

Professor Haciibrahimoglu specializes in thoracic surgical oncology, including esophageal cancer, with expertise in VATS (Video Assisted Thoracoscopic Surgery).

• Trained at University of Paris-Sud and Vienna Medical School
• Over 20 years of experience in thoracic surgery
• Member of European Society of Thoracic Surgeons
• Published 13 international papers on thoracic surgery

15,000+ surgical procedures performed – Dr. de Lacy is a pioneer in minimally invasive techniques for esophageal cancer at Hospital Quiron Barcelona.

• Performs 1,000+ interventions annually using laparoscopic and robotic methods
• President of the Association of Surgeons-Endoscopists in Europe
• World-renowned pioneer in gastrointestinal surgery techniques
• Lecturer on advanced laparoscopy and surgical techniques

Deputy Head of the Department of Oncology at Rambam Medical Center – specializes in complex esophageal cancer cases.

• Extensive experience in oncology with a focus on esophageal cancer
• Works at a leading medical center in Israel
• Handles both diagnosis and treatment planning

Prof. Keun Chil Park, MD heads the Division of Hematology-Oncology at Samsung Medical Center with a strong focus on esophageal cancer.

• Special interests in lung, head and neck, and esophageal cancers
• Member of multiple prestigious oncology associations including ASCO and ESMO
• Graduated from Seoul National University College of Medicine

Dr. Choi Yong Soo is a thoracic surgeon at Samsung Medical Center, specializing in esophageal cancer treatments.

• Expert in surgical interventions for complex esophageal cancer cases
• Works at one of South Korea's leading medical institutions
• Focuses on providing personalized treatment plans

Dr. Alexander Beny leads the Gastrointestinal Malignant Service at Rambam Medical Center, specializing in esophageal cancer.

• Board-certified in both Medical and Radiation Oncology
• Headed multiple oncology departments, including the Italian General Hospital
• Trained in modern Brachytherapy Techniques through ESTRO
• European Community Board certified in Medicine

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.